Telerehabilitation in COVID-19 Survivors

Bandırma Onyedi Eylül University

Status: Completed

Conditions: COVID-19; Telerehabilitation

Treatments: Other: home exercise program; Other: informed program; Other: telerehabilitation

Study type: Interventional

Funder types: Other

Identifiers

NCT05074979

CDemir

Details and patient eligibility

About

This study was carried out in the post-acute period of the telerehabilitation program in individuals with dyspnea who had COVID-19; It will be done to examine the effects on dyspnea, exercise capacity, respiratory functions, activities of daily living, muscle strength, muscle oxygenation, fatigue and quality of life parameters.

Enrollment: 36 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with COVID-19 by Computed Tomography (CT) or PCR test between the ages of 18-75,
• Do not have any orthopedic or neurological disease that will affect exercise capacity,
• Individuals who can take and execute verbal orders,
• Have had COVID-19 and at least 2 weeks have passed since the completion of the treatment,
• Individuals who have a computer or smart phone with a camera and internet connection and have the ability to use it (the participant himself or one of his family members living in the same house),
• Individuals who are sedentary (those whose physical activity level is inactive according to the Turkish version of the International Physical Activity Questionnaire (UFAA)),
• Having dyspnea at level 2 or 3 on the Medical Research Council Dyspnea Scale.

Exclusion criteria

• Those who have not had COVID-19 or acute period patients who are experiencing COVID-19,
• Individuals who cannot be contacted,
• Individuals with chronic heart disease,
• Those with concomitant uncontrolled disease; uncontrolled hypertension (resting blood pressure ≥160 /100mmHg), uncontrolled diabetes (random instantaneous blood glucose>16.7 mmol/l, HbA1C>7.0%),
• Those with concomitant severe organic disease (unstable hemodynamic heart disease, heart failure causing movement limitation, unstable angina, MI or other cardiac disease in the last 12 years),
• Individuals with cerebrovascular disease in the last 6 months,
• Those with digestive system ulcer, thyroid dysfunction or active stage of tuberculosis,
• Patients with Chronic Kidney Failure stage 3 and above according to Glomerular Filtration Rate (GFR),
• Individuals who have undergone intraraticular medication or surgery from their lower extremities in the last 6 months,
• Individuals who cannot walk independently,
• Individuals with any mental illness that may prevent them from living independently or receiving treatment,
• Uncooperative individuals for assessment and rehabilitation programs,
• Those with alcohol or substance addiction,
• Those who are pregnant, suspected of pregnancy or considering becoming pregnant,
• Participants in another study within the last 3 months or currently.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

36 participants in 3 patient groups

control group

Other group

Description:

While other groups continue their exercise program for 6 weeks, this group will only be informed after COVID 19.

Treatment:

Other: informed program

home exercise program group

Experimental group

Description:

this group will implement COVID 19 home exercise program.

Treatment:

Other: home exercise program

telerehabilitation group

Experimental group

Description:

this group will implement COVID 19 telerehabilitation program.

Treatment:

Other: telerehabilitation